Sort
15,842 grants matching “pancreatic cancer”
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
$208,628Deborah A Altomare · University Of Central Florida · R21 · FY2010 · CA
Accurate Determination of Dose to Mobile Organs at Risk in Hypofractionated Ablative Radiotherapy for Locally Advanced Pancreatic Cancer
$208,548Gikas S Mageras · Sloan-Kettering Inst Can Research · R21 · FY2019 · CA
Managing prostate cancer metastasis using vitamin k2
$208,539Gnanasekar Munirathinam · University Of Illinois At Chicago · R21 · FY2015 · CA
Targeted nanotechnology for the pancreatic tumor immune microenvironment
$208,538Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2024 · EB
Immune Evasion in Pancreatic Cancer
$208,413Mark Stephen Diamond · University Of Pennsylvania · K08 · FY2021 · CA
Immune Evasion in Pancreatic Cancer
$208,413Mark Stephen Diamond · University Of Pennsylvania · K08 · FY2019 · CA
Immune Evasion in Pancreatic Cancer
$208,413Mark Stephen Diamond · University Of Pennsylvania · K08 · FY2020 · CA
Chemoprevention of pancreatic cancer witli antidiabetic agents
$208,341Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2012 · CA
Targeted neuroendocrine cancer therapy using Verrucarin A
$208,271Renata Jaskula-Sztul · University Of Alabama At Birmingham · R21 · FY2022 · CA
Chemotherapy of Pancreatic Cancer: Induction of Apoptosis or Senescence
$208,238David E Modrak · Ctr For Molecular Medicine/Immunology · R21 · FY2009 · CA
Cellular Response to cMet Endocytosis
$208,202Lisa A. Elferink · University Of Texas Med Br Galveston · R01 · FY2008 · CA
Cellular Response to cMet Endocytosis
$208,202Lisa A. Elferink · University Of Texas Med Br Galveston · R01 · FY2010 · CA
Cellular Response to cMet Endocytosis
$208,202Lisa A. Elferink · University Of Texas Med Br Galveston · R01 · FY2007 · CA
Aberrant Glycosylation Signature in Pancreatic Cancer
$208,128Sheng Pan · University Of Washington · R21 · FY2012 · CA
Mildly acidic tumor microenvironment for diagnostic and therapeutic nanomedicine
$208,074Jennica L. Zaro · University Of Southern California · R21 · FY2014 · CA
Tissue and Pathology Resources
$207,986Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2008 · CA
Program the Immune System against RAS-driven Cancer
$207,879Xiaojing J Gao · Stanford University · R61 · FY2024 · CA
Project 2: Endoscopic Photodynamic and Combination Therapy for Local and Metastatic Pancreatic Tumors
$207,827Stephen Pereira · Massachusetts General Hospital · P01 · FY2016 · CA
Improving Efficacy of Local Drug Delivery Using Ultrasound
$207,792Agata A Exner · Case Western Reserve University · R21 · FY2019 · EB
MOB-5 IN COLORECTAL &PANCREATIC CANCER
$207,688Vanderbilt University · R01 · FY2001 · CA
FOLATE AMINOBORONIC ACIDS AS TARGETED ANTI-CANCER AGENTS
$207,675Venkatram R Mereddy · University Of Minnesota Duluth · R15 · FY2008 · CA
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY
$207,536Roswell Park Cancer Institute Corp · R01 · FY2002 · CA
Develop and Characterize a Novel Animal Model of Pancreatic Cancer
$207,495Baoan Ji · Mayo Clinic Rochester · R21 · FY2012 · CA
Defining the Role for A Lipid Kinase in the Progression of Pancreatic Cancer
$207,495Kun Ling · Mayo Clinic Rochester · R21 · FY2015 · CA
Aptamers as Proteomic Tools for Pancreatic Cancer Biomarker Identification
$207,495Rebekah White · Duke University · R21 · FY2015 · CA